Document Detail


Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings.
MedLine Citation:
PMID:  24697297     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
First discovered in 1966 as an inflammatory cytokine, MIF (macrophage migration inhibitory factor) has been extensively studied for its pivotal role in a variety of inflammatory diseases, including rheumatoid arthritis and atherosclerosis. Although initial studies over a decade ago reported increases in circulating MIF levels following acute MI (myocardial infarction), the dynamic changes in MIF and its pathophysiological significance following MI have been unknown until recently. In the present review, we summarize recent experimental and clinical studies examining the diverse functions of MIF across the spectrum of acute MI from brief ischaemia to post-infarct healing. Following an acute ischaemic insult, MIF is rapidly released from jeopardized cardiomyocytes, followed by a persistent MIF production and release from activated immune cells, resulting in a sustained increase in circulating levels of MIF. Recent studies have documented two distinct actions of MIF following acute MI. In the supra-acute phase of ischaemia, MIF mediates cardioprotection via several distinct mechanisms, including metabolic activation, apoptosis suppression and antioxidative stress. In prolonged myocardial ischaemia, however, MIF promotes inflammatory responses with largely detrimental effects on cardiac function and remodelling. The pro-inflammatory properties of MIF are complex and involve MIF derived from cardiac and immune cells contributing sequentially to the innate immune response evoked by MI. Emerging evidence on the role of MIF in myocardial ischaemia and infarction highlights a significant potential for the clinical use of MIF agonists or antagonists and as a unique cardiac biomarker.
Authors:
Nalin H Dayawansa; Xiao-Ming Gao; David A White; Anthony M Dart; Xiao-Jun Du
Related Documents :
12539097 - Comparability of 12-lead ecgs derived from easi leads with standard 12-lead ecgs in the...
24570747 - The clinical significance of anticardiolipin antibody levels in patients with acute myo...
23341477 - Emotions delay care-seeking in patients with an acute myocardial infarction.
12398877 - Effects of pre-existing left ventricular hypertrophy on ventricular dysfunction and rem...
19394287 - Utility of plasma n-terminal pro-brain natriuretic peptide (nt-probnp) to distinguish b...
10532207 - Inhibitors of the platelet receptor glycoprotein iib-iiia and complications during perc...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical science (London, England : 1979)     Volume:  127     ISSN:  1470-8736     ISO Abbreviation:  Clin. Sci.     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-04-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905731     Medline TA:  Clin Sci (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  149-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin sys...
Next Document:  Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds.